Cargando…
31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335421/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.032 |
| _version_ | 1783733100487901184 |
|---|---|
| author | Lim, C. Eiting, E. O'Neill, A. Farraj, R. Koshy, S. Simms, C. Devlin, A. Nunez, J. Calderon, Y. |
| author_facet | Lim, C. Eiting, E. O'Neill, A. Farraj, R. Koshy, S. Simms, C. Devlin, A. Nunez, J. Calderon, Y. |
| author_sort | Lim, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8335421 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83354212021-08-04 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 Lim, C. Eiting, E. O'Neill, A. Farraj, R. Koshy, S. Simms, C. Devlin, A. Nunez, J. Calderon, Y. Ann Emerg Med Abstract Published by Mosby, Inc. 2021-08 2021-08-04 /pmc/articles/PMC8335421/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.032 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Abstract Lim, C. Eiting, E. O'Neill, A. Farraj, R. Koshy, S. Simms, C. Devlin, A. Nunez, J. Calderon, Y. 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 |
| title | 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 |
| title_full | 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 |
| title_fullStr | 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 |
| title_full_unstemmed | 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 |
| title_short | 31 Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19 |
| title_sort | 31 emergency department-based monoclonal antibody therapy for patients with mild to moderate covid-19 |
| topic | Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335421/ http://dx.doi.org/10.1016/j.annemergmed.2021.07.032 |
| work_keys_str_mv | AT limc 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT eitinge 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT oneilla 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT farrajr 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT koshys 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT simmsc 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT devlina 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT nunezj 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 AT calderony 31emergencydepartmentbasedmonoclonalantibodytherapyforpatientswithmildtomoderatecovid19 |